← back to search

Luisa Cimmino

University of Miami · US
Area of research
Molecular Biology · Hematology
Research interest
Research interests include Acute Myeloid Leukemia Research, Retinoids in leukemia and cellular processes, Epigenetics and DNA Methylation, and Estrogen and related hormone effects.
h-index
16
citations
2,407
works
96
NIH funding
primary concept
email

Recent publications

Elevated B12 serum levels are associated with the presence of clonal hematopoiesis
Blood Neoplasia 2025cited by 3position: lastdoi
Clonal hematopoiesis related TET2 loss-of-function impedes IL1β-mediated epigenetic reprogramming in hematopoietic stem and progenitor cells
Nature Communications 2023cited by 63position: middledoi
Tracking the Evolution of Therapy-Related Myeloid Neoplasms Using Chemotherapy Signatures
Blood 2023cited by 37position: middledoi
Oxidized mC modulates synthetic lethality to PARP inhibitors for the treatment of leukemia
Cell Reports 2023cited by 17position: lastdoi
Corrigendum to “Hacking macrophage-associated immunosuppression for regulating glioblastoma angiogenesis” [Biomater. 161 (2018) 164–178]
Biomaterials 2022cited by 3position: middledoi
Epigenetic Regulation of Genomic Stability by Vitamin C
Frontiers in Genetics 2021cited by 98position: lastdoi
Tonic interferon restricts pathogenic IL-17-driven inflammatory disease via balancing the microbiome
eLife 2021cited by 38position: middledoi
p300 suppresses the transition of myelodysplastic syndromes to acute myeloid leukemia
JCI Insight 2021cited by 19position: middledoi
B Vitamins and One-Carbon Metabolism: Implications in Human Health and Disease
Nutrients 2020cited by 392position: lastdoi
Novel combinations to improve hematopoiesis in myelodysplastic syndrome
Stem Cell Research & Therapy 2020cited by 11position: middledoi
Reprogramming the Epigenome With Vitamin C
Frontiers in Cell and Developmental Biology 2019cited by 119position: lastdoi
TET2 Deficiency Causes Germinal Center Hyperplasia, Impairs Plasma Cell Differentiation, and Promotes B-cell Lymphomagenesis
Cancer Discovery 2018cited by 164position: middledoi
Mutant IDH1 Downregulates ATM and Alters DNA Repair and Sensitivity to DNA Damage Independent of TET2
Cancer Cell 2016cited by 197position: middledoi
Mutational Cooperativity Linked to Combinatorial Epigenetic Gain of Function in Acute Myeloid Leukemia
Cancer Cell 2015cited by 247position: middledoi
TET1 is a tumor suppressor of hematopoietic malignancy
Nature Immunology 2015cited by 226position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Feng‐Chun Yang · The University of Texas at San Antonio Health Science Center2 papers (2020–2021)Peter D. Lyon · University of Miami2 papers (2020–2025)Huimin Geng · University of California, San Francisco1 papers (2015–2015)Stephen D. Nimer · University of Miami1 papers (2021–2021)Marina Konopleva · Anderson University - South Carolina1 papers (2025–2025)Aristeidis G. Telonis · University of Miami1 papers (2025–2025)Isabelle Marié · New York University1 papers (2021–2021)Byron Fang · University of Miami1 papers (2020–2020)Pratip K. Chattopadhyay · New York University1 papers (2021–2021)Sofia Mohammad · University of Miami1 papers (2021–2021)Camille Lobry · Inserm1 papers (2015–2015)Renee‐Tyler T. Morales · University of Pennsylvania1 papers (2022–2022)Thomas Trimarchi · BridgeBio (United States)1 papers (2015–2015)Daniel Goldman · Johns Hopkins Medicine1 papers (2023–2023)Xin Cui · New York University1 papers (2022–2022)Emily L. Ahearn · University of Miami1 papers (2019–2019)Mingjiang Xu · The University of Texas Health Science Center at San Antonio1 papers (2021–2021) · 1 papers (2020–2020)Pierre-Jacques Hamard · Memorial Sloan Kettering Cancer Center1 papers (2021–2021)Jasper Mullenders · Hycult Biotech (Netherlands)1 papers (2015–2015)